TPO线DTC:1635

Rodis Paparodis1,2, Sarantis Livadas3, Evangelos Karvounis4

  • 1Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences (formerly Medical College of Ohio), University of Toledo, Toledo, OH 43606, USA.

概括

较高的甲状腺过氧化酶抗体 (TPO-Abs) 标位与差异化甲状腺癌 (DTC) 的风险降低相关. 这项研究发现,增加TPO-Ab水平在接受甲状腺切除术的患者中提供了对DTC发展的线性保护作用.